Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Two-pore-domain potassium channel proteins are a family of potassium-selective ion channels characterized by the presence of two pore-forming domains per subunit. Unique among potassium channels, they assemble as dimers to form a functional channel, with the four total pore domains creating the selectivity filter. They are responsible for background or leak potassium currents that help stabilize the resting membrane potential and regulate excitability in many types of cells, including neurons and cardiomyocytes. Members of this family include channels such as TWIK-1, TREK-1, TASK-1, and others. K2P channels are regulated by diverse mechanisms, including pH, mechanical stretch, lipids, temperature, and G-proteins. They are therapeutic targets for pain modulation, neuroprotection, migraine, and possibly cardiac and neurological disorders. Channelopathies involving mutations in K2P channel genes can lead to diseases such as migraine and arrhythmias. These channels are also pharmacological targets for drugs like general anesthetics and neuroprotective agents. For computational or drug discovery purposes, it is important to specify the particular member of the K2P family as each has distinct functional and pharmacological properties. The entry "Tandem pore domain potassium channel protein" is not incorrect per se, but is a family name; individual druggable entities often refer to specific members (e.g., KCNK2/TREK-1, KCNK18/TRESK).
Channel activation (increase potassium leak, hyperpolarize membrane, reduce neuronal excitability); Channel inhibition (decrease potassium leak, depolarize membrane, enhance excitability)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Two-pore-domain potassium channel protein (K2P channel).